BrB-101
Development of a topical gene-editing treatment to restore Collagen VII...
01 January, 2021
Archive
01 December, 2020
Gene therapy for airway disease
Combined respiratory epithelial cell and gene therapy for amelioration of respiratory symptoms in children with Junctional Epidermolysis Bullosa...
01 October, 2020
RDEB gene-edited skin
Pre-clinical and clinical trial for using gene-edited skin in Recessive Dystrophic Epidermolysis Bullosa...
01 September, 2020
NanoCol
A nanoneedle bandage for topical intracellular COL7A1 gene therapy to accelerate wound healing in Recessive Dystrophic Epidermolysis Bullosa...
01 September, 2018
EBGRAFT
Phase I/II ex vivo gene therapy clinical trial for RDEB using autologous skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector...
01 December, 2016
Next generation genome editing
Next generation genome editing for Recessive Dystrophic Epidermolysis Bullosa...
01 April, 2016
Ocular stem cell regeneration
Stem cell regeneration of the ocular surface in Recessive Dystrophic Epidermolysis Bullosa...
01 July, 2015
Lenticol F
Phase I study of lentiviral-mediated COL7A1 gene-modified autologous fibroblasts in adults with Recessive Dystrophic Epidermolysis Bullosa...
01 January, 2015
ADSTEM
A phase I/II study to evaluate allogeneic mesenchymal stromal cells for the treatment of skin disease in adults with Recessive Dystrophic Epidermolysis Bullosa...
01 January, 2013
TALEN-based gene editing
A TALEN-based approach to developing safer, more effective treatments for people with Epidermolysis Bullosa...